ArticlePregnancy (Hoboken, N.J.)2026
Postpartum follow-up and Edinburgh Postnatal Depression Scale scores in prenatally suspected placenta accreta spectrum.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: To assess the impact of prenatal suspicion of placenta accreta spectrum (PAS) on attendance of postpartum care and Edinburgh Postnatal Depression Scale (EPDS) scores, with stratification by confirmed PAS based on clinical or pathologic PAS grading. Study design: Matched cohort of singleton pregnancies that delivered 2010-2024. Patients with prenatal suspicion of PAS were matched to patients without this concern by age (within 5 years), number of prior cesareans, term or preterm delivery, and hypertensive disorders of pregnancy. Exclusions were fetal anomalies, stillbirth, neonatal death, and those without follow-up data. Maternal demographics, scheduled and attended postpartum follow-up, and EPDS scores were compared between patients with and without prenatal suspicion of PAS. Sub-analysis included confirmed diagnosis of PAS (true positive vs. false positive). Availability of EPDS scores was assessed for all cohorts. Results: Of 202 patients with prenatally suspected PAS, 112 had available EPDS scores. This was different from patients without this concern where 176 scores were available (55% vs. 87%, Conclusion: Patients with prenatal suspicion of PAS were more frequently assigned additional subspeciality follow-up and less likely to attend their routine postpartum visit and have EPDS scores available. Of patients with prenatally suspected PAS regardless of whether PAS was confirmed, EPDS scores did not differ from patients without this concern. While potentially reassuring, our findings highlight the need for integrated PAS care to address mental health, removing barriers for assessment and enabling referral if indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.